There is provided the use of a functional thylakoid extract, particularly in admixture with a physiologically acceptable carrier, in pharmaceutical application, in the treatment of inflammatory bowel disease, and method for the treatment thereof. The inflammatory bowel disease may comprise several diseases associated with inflammation of the small intestine, large intestine (colon), rectum or anus (anal sphincter), and may be particularly selected from ulcerative colitis and Crohn's disease.

There is provided the use of a functional thylakoid extract, particularly in admixture with a physiologically acceptable carrier, in pharmaceutical application, in the treatment of inflammatory bowel disease, and method for the treatment thereof. The inflammatory bowel disease may comprise several diseases associated with inflammation of the small intestine, large intestine (colon), rectum or anus (anal sphincter), and may be particularly selected from ulcerative colitis and Crohn's disease.

A dietary supplement composition is formulated in a therapeutic amount to treat and alleviate symptoms of joint pain in an animal such as a human patient or non-human animal. The dietary supplement composition comprises hyaluronic acid/hyaluronan, which includes pro-inflammatory low molecular weight sodium hyaluronate fragments having a molecular weight of 0.5 to 300 kilodaltons (kDa) in an oral dosage form. The hyaluronic acid/hyaluronan also includes hyaluronic acid/hyaluronan having a molecular weight greater than the 0.5 to 300 kDa range. The composition may include eggshell membrane.

A dietary supplement composition is formulated in a therapeutic amount to treat and alleviate symptoms of joint pain in an animal such as a human patient or non-human animal. The dietary supplement composition comprises hyaluronic acid/hyaluronan, which includes pro-inflammatory low molecular weight sodium hyaluronate fragments having a molecular weight of 0.5 to 300 kilodaltons (kDa) in an oral dosage form. The hyaluronic acid/hyaluronan also includes hyaluronic acid/hyaluronan having a molecular weight greater than the 0.5 to 300 kDa range. The composition may include eggshell membrane.

The present invention relates to compositions and methods for promoting the immune health of an animal or human by administering compositions or mixtures of water-soluble components derived from a genus Euglena organism that are capable of stimulating immune system activity in the absence of beta-glucan.

The present invention relates to compositions and methods for promoting the immune health of an animal or human by administering compositions or mixtures of water-soluble components derived from a genus Euglena organism that are capable of stimulating immune system activity in the absence of beta-glucan.

Methods for improving the visual processing of a healthy infant by administering a composition comprising RRR-alpha-tocopherol to the infant are disclosed. Methods for improving the visual acuity of a healthy infant by administering a composition comprising RRR-alpha-tocopherol to the infant are also disclosed. Methods for improving the development of the visual processing, visual acuity, or both, of an infant by administering a composition comprising RRR-alpha-tocopherol to the infant are also disclosed.

Methods for improving the visual processing of a healthy infant by administering a composition comprising RRR-alpha-tocopherol to the infant are disclosed. Methods for improving the visual acuity of a healthy infant by administering a composition comprising RRR-alpha-tocopherol to the infant are also disclosed. Methods for improving the development of the visual processing, visual acuity, or both, of an infant by administering a composition comprising RRR-alpha-tocopherol to the infant are also disclosed.

Methods and formulations for increasing the water solubility and/or bioavailability of lipophilic natural compounds are disclosed. The formulations may be employed to make liquid filled capsules or clear and stable beverages containing therapeutic amounts of the active ingredients, for example.

Methods and formulations for increasing the water solubility and/or bioavailability of lipophilic natural compounds are disclosed. The formulations may be employed to make liquid filled capsules or clear and stable beverages containing therapeutic amounts of the active ingredients, for example.